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Introduction: Guidelines support the use of enteral nutrition to improve clinical outcomes in critical illness; however,
the optimal calorie and protein intake remains unclear. The purpose of this meta-analysis was to quantitatively analyze
randomised controlled trials with regard to clinical outcomes related to varying calorie and protein administration in
critically ill adult patients.
Method: We searched Medline, EMBASE, and Cochrane databases to identify randomised controlled trials that
compared the effects of initially different calorie and protein intake in critical illness. The risk ratio (RR) and weighted
mean difference with 95% confidence intervals (CI) were calculated using random-effects models. The primary
endpoint was mortality; secondary endpoints included infection, pneumonia, gastrointestinal intolerance, hospital and
intensive care unit lengths of stay, and mechanical ventilation days.
Results: In the eight randomised controlled trials that enrolled 1,895 patients there was no statistical difference
between the low-energy and high-energy groups in mortality (RR, 0.90; 95% CI, 0.71 to 1.15; P = 0.40), infection
(RR, 1.09; 95% CI, 0.92 to 1.29; P = 0.32), or the risk of gastrointestinal intolerance (RR, 0.84; 95% CI, 0.59 to 1.19; P = 0.33).
In subgroup analysis, the low-energy subgroup, fed 33.3 to 66.6% of goal energy, showed a lower mortality than the
high-energy group (RR, 0.68; 95% CI, 0.51 to 0.92; P = 0.01). The improvements in mortality and gastrointestinal
intolerance were absent when calorie intake was >66.6% of goal energy in the low-energy group. High-energy intake
combined with high-protein intake reduced the infections (RR, 1.25; 95% CI, 1.04 to 1.52; P = 0.02); however, when the
daily protein intake was similar in both groups, a high-energy intake did not decrease the infections. No statistical
differences were observed in other secondary outcomes.
Conclusion: This meta-analysis indicates that high-energy intake does not improve outcomes and may increase
complications in critically ill patients who are not malnourished. Initial moderate nutrient intake (33.3 to 66.6% of goal
energy), compared to high energy, may reduce mortality, and a higher protein intake combined with high energy
(≥0.85 g/kg per day) may decrease the infection rate. However, the contribution of energy versus protein intake to
outcomes remains unknown.Introduction
Enteral nutrition (EN) may not only supply nutrition to
patients but also protect intestinal epithelial cells, im-
prove intestinal tight junctions, support intestinal struc-
ture and function, and prevent bacterial translocation
[1-5]. However, no such beneficial clinical effect of EN* Correspondence: nanjinglining@163.com
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unless otherwise stated.has been observed in the first large randomised con-
trolled trial (RCT) comparing isocaloric EN to parenteral
nutrition (PN) [5]. Critically ill patients are often in a
catabolic state because of the influence of inflammatory
cytokines and stress hormones [6]. As a result, patients
in the ICU may be at an increased risk of progressive
underfeeding, which can result in malnutrition. To avoid
malnutrition, the guidelines of several health organisa-
tions advocate early EN [7-10]. Unfortunately, critically
ill patients may not receive sufficient calories and protein
via EN because of gastrointestinal dysmotility, particularlyis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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oric target may lead to high gastric residual volumes,
which may increase the risk of aspiration pneumonia and
result in longer ICU stays and increased mortality [5,12].
However, a limited-energy supplement that is provided
because of gastrointestinal intolerance can increase the
risk of malnutrition, which may be associated with im-
paired immune function, weakened or wasted muscles, in-
creased duration of mechanical ventilation, and infectious
complications [13,14]. Therefore, the initial optimal cal-
orie and protein recommendations for critically ill patients
are still unclear.
The European Society for Clinical Nutrition and Me-
tabolism’s guidelines suggest that an exogenous energy
supply in excess of 20 to 25 kcal/kg body weight per day
may be associated with less favourable outcomes during
the acute phase of a critical illness (grade C) [10]. Simi-
larly, the American Society for Parenteral and Enteral
Nutrition reported that providing >50% to 65% of goal
calories should be attempted as a means of achieving the
clinical benefit of EN during the first week of hospital-
isation (grade C) [4,7]. However, the Canadian Critical
Care Nutrition Clinical Practice Guidelines, because of
insufficient data, did not recommend using hypocaloric
EN in critically ill patients [9]. Because these three
guidelines were published before 2014, when three rele-
vant RCTs were published, the summary of evidence for
EN in critical illness requires updating. Furthermore, the
level of evidence of these recent RCTs has not been
evaluated.
A cohort study of patients in a respiratory ICU re-
ported that inadequate calorie delivery is associated with
higher odds of mortality [15]. Surprisingly, a study com-
paring hypocaloric and normocaloric nutrition in critic-
ally ill patients demonstrated that initial hypocaloric
feeding did not affect the hospital or ICU mortality [16].
Conflicting results have even been observed within the
same study; the Tight Calorie Control Study showed that
near-target energy intake was associated with lower hos-
pital mortality in the per protocol analysis, but increased
the duration of the ICU stay and rate of infectious compli-
cations in the intention to treat analysis [17]. Therefore,
given the heterogeneity of these studies, a meta-analysis of
more recent RCTs is needed. The current meta-analysis of
eight RCTs aimed to compare initial hypocaloric EN ver-




In this systematic review, we conducted a search of the
published literature to identify all relevant clinical trials
using the keywords or MeSH headings of ‘trophic feeding’,
‘hypocaloric nutrition’, ‘permissive underfeeding’, ‘gradualenteral nutrition’, ‘standard enteral nutrition’, ‘intensive en-
teral nutrition’, ‘concentrated enteral nutrition’, ‘hypercalo-
ric nutrition’, ‘normocaloric nutrition’, ‘full feeding’, ‘critical
illness’, ‘critically ill’, ‘ICU’, ‘acute lung injury’, ‘respiratory
insufficiency’, and ‘intensive care’ in combination with the
Boolean operators AND and OR. Two of the authors
(Feng Tian and Xinying Wang) independently per-
formed computerised searches in the MEDLINE,
EMBASE, and Cochrane Controlled Trials Register data-
bases. We also searched previous review articles for add-
itional original studies. The final search was conducted
on 1 November 2014. No language restrictions were in-
cluded in the searches. Additionally, abstracts from
major scientific meetings were included if they were
available for data extraction; authors were approached
for additional or missing data, if necessary.
Inclusion criteria
Two investigators (Feng Tian and Xuejin Gao) independ-
ently reviewed all original studies to determine inclusion or
exclusion; in the case of disagreement, a third author was
consulted. Original studies were selected for inclusion if
they met the following criteria: 1) the research design was
an RCT or randomized trial or study; 2) the population
comprised critically ill adult patients admitted to the ICU
(>16 years old); 3) the intervention of the study was
designed such that the two groups received significantly
different calorie intakes by EN; and 4) the clinical outcome
of overall mortality of critically ill patients was reported.
Exclusion criteria
Studies were excluded if they met either of the following
criteria: 1) the target calorie supply was different
between the two groups; and 2) EN was administered
for <2 days.
Data extraction
Two authors (Feng Tian and Xuejin Gao) independently
extracted the following variables where they were pub-
lished and available: demographics, sample size, critical
illness severity, amount of daily calorie and protein
intake, body mass index (BMI), intervention provided in
both groups, and clinical outcomes.
Assessment of quality and risk of bias
The same two authors independently assessed the study
quality and risk of bias using the methods detailed in the
Cochrane Handbook for Systematic Reviews of Interven-
tions [18]. Disagreements were resolved in pairs of au-
thors by consensus. The six quality criteria were random
sequence generation, allocation concealment, blinding of
participants and personnel, blinding of outcome assess-
ment, incomplete outcome data, and selective reporting.
Figure 1 Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) statement and accompanying study flow
diagram. RCT, randomised controlled trial.
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The primary outcome of this meta-analysis was overall
mortality. Hospital mortality in all studies was combined.
If hospital mortality was not reported, 60- or 90-day or
ICU mortality was used instead. Secondary outcomes in-
cluded infections (bacteraemia or sepsis was used if the
number of infection cases was not reported), pneumonia
(ventilator-associated pneumonia and infectious pneumo-
nia), length of stay (LOS) in both hospital (LOS-HOS) and
ICU (ICU LOS), and mechanical ventilation days (MVD);
these were also pooled for all studies. Despite differences
in the definition of gastrointestinal intolerance (high re-
sidual gastric volume, regurgitation, vomiting, noninfec-
tious diarrhoea, or abdominal distension), we combined
the outcomes where diarrhoea was reported.
The risk ratio (RR) and associated 95% confidence inter-
val (CI) were used to summarize binary outcomes including
mortality, infections, and pneumonia. The overall weighted
mean difference (WMD) with 95% CI was estimated for
LOS and MVD. A more conservative random-effects model
was used in this meta-analysis because of anticipated
heterogeneity. Statistical heterogeneity among trials is
expressed as the P value (Cochran’s Q statistic), where a
P < 0.05 and I2 statistic >50% indicated significant hetero-
geneity. Subgroup analyses were conducted to find the
source of heterogeneity, and a test for heterogeneity
interaction was performed to determine whether there was
a difference in effect sizes between subgroups. The
subgroups were chosen based on their suspected influences
on the analyses and previous relevant studies. For instance,
the varying calorie intake between studies could influence
the aggregate results. Therefore, the eight studies were
divided into three subgroups according to the percentage of
target energy achieved in the low-energy (LE) group
(<33.3%, 33.3 to 66.6%, and >66.6%). The cut-offs of 33.3%
and 66.6% were based on a previous cohort study and a
recent meta-analysis [19,20]. The overlap in studies was
managed with subgroup analysis. Funnel plots were used to
assess possible bias in reporting and publication; forest
plots are presented as pooled data with Review Manager,
version 5.3 (Copenhagen: The Nordic Cochrane Centre,
The Cochrane Collaboration, 2014).
Results
Results of the literature search and study selection
Our detailed search strategy is illustrated in the flow dia-
gram in Figure 1, which follows the strategy recom-
mended by the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses group. Our initial search of
the electronic databases yielded 6,701 articles: 5,128 arti-
cles were duplicates; 808 articles did not include adult
patients; 494 articles were not RCTs; 79 articles were of
PN; 145 articles were not relevant; five articles were not
available; six articles were reviews or meta-analyses;
Figure 2 Risk of bias summary: authors’ judgments regarding the
risk of bias factor for each included study.
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were conducted for tube position; five articles were re-
lated to immunonutrition; three articles involved re-
sidual volume; and one article described body position.
Of the 14 potentially relevant articles that were selected
for further assessment, six were excluded: two studies
reported that both groups were similar, two studies did
not administer EN to the LE group, one reported differ-
ent goal energy levels between the two groups, and one
study reported blood glucose and albumin as outcomes,
rather than mortality. Thus, eight studies published be-
tween 1999 and 2014 fulfilled the inclusion criteria; as a
result, 1,895 patients were included in this meta-analysis,
of which 951 were in the LE group and 944 were in the
high-energy (HE) group [21-28].
Risk of bias in included studies
Randomisation methods were reported in all eight stud-
ies. Allocation concealment was used in six trials using
sealed envelopes [21-26], and, although one study did
not state allocation concealment, we agreed that this
study’s allocation method was low risk for our purposes
because it used a web-based randomization system [27].
Because of different nutrition doses and titration needs
for tolerance and gastric residuals, only two studies used
a double-blind design [25,28]. Protocol violations after
randomisation occurred in four studies [21,23,25,27].
The assessment for risk of bias in each study is shown in
Figure 2. When more than four studies were included,
funnel plots were used to assess possible reporting or
publication bias (Figures 3, 4 and 5). Figures 3 and 5
show the approximate symmetry of the funnel plots for
mortality and pneumonia. Figure 4 shows the asymmetry
of the funnel plots for infection; in light of this, we per-
formed a sensitivity analysis to evaluate the robustness
of the pooled outcome.
Characteristics of the included studies
The basic characteristics of patients in the included
studies are shown in Tables 1 and 2. The mean age of
patients was >50 years, except in one study whose patients
were <35 years of age [28]. The intervention duration in
five studies was 5 to 7 days [21,24,26-28] and >10 days
in three studies [22,23,25]. The Acute Physiology and
Chronic Health Evaluation (APACHE) II scores in four
studies were >20 [21,22,25,26] and <20 in two studies
[23,28]. One study used the Simplified Acute Physiology
Score [24], and another study used APACHE III scores
[27]. The mean BMI of patients in seven studies was
>25 kg/m2 [21-27]; one study did not report BMI [28].
The mean daily delivered caloric and protein levels dif-
fered among studies. In the LE group, the mean daily
percentage of target calories in two studies was <33.3%;
in four studies, it was between 33.3% and 66.6%; and intwo studies, it was >66.6%. In the HE group, the per-
centage of target calories for patients was >70% in seven
studies and >90% in two studies, but it was 59.2% in one
study. Although the caloric intake was 59.2% for the HE
group in the study by Taylor and colleagues [28], the
mean target calorie intake was 35 kcal/kg per day.
Therefore, the actual energy intake in the HE group was
20.72 kcal/kg per day (in the LE group it was 12.88 kcal/kg
per day), which was similar to the caloric intake of the HE
group in the other studies. Among the six studies
[21-23,25,26,28] that reported daily protein intake levels,
the protein levels were different between the HE and LE
groups in three studies [22,26,28]. In one study, the protein
intake was not reported clearly; however, based on the
author’s reply that the use of different enteral formulas led
to different protein amounts, the different levels of protein
intake for the two groups could be estimated [27]. In the
studies in the different-protein subgroup, the daily protein
intake was ≥0.85 g/kg per day in each HE group and
≤0.68 g/kg per day in each LE group, when adjusted by
ideal body weight.
Meta-analysis of primary outcomes
The primary meta-analysis included all eight studies (1,895
participants) and revealed that mortality was not signifi-
cantly different for patients in the LE group compared
Figure 3 Funnel plots showing the impact of initial low energy intake on mortality. LE, low-energy; RR, risk ratio; SE, standard error.
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P = 0.40; I2 = 31%; P = 0.18). Subgroup analysis was per-
formed according to the percentage of the goal energy
achieved and showed that mortality was significantly dif-
ferent among the three subgroups. Compared with the HE
group, mortality was significantly lower in the LE group
(fed between 33.3% and 66.6% of the goal energy in the LE
group; RR, 0.68; 95% CI, 0.51 to 0.92; P = 0.01; I2 = 0%;
P = 0.43). In contrast, compared with the HE group,
mortality was not different in the LE subgroup that was
fed <33.3% (RR, 1.06; 95% CI, 0.86 to 1.31; P = 0.57;
I2 = 0%; P = 0.77) or >66.6% of the goal energy (RR, 1.06;
95% CI, 0.58 to 1.93; P = 0.86; I2 = 31%; P = 0.23).
There was significant heterogeneity among the subgroups
(I2 = 65.7%; P = 0.05) (Figure 6). Subgroup analysis wasFigure 4 Funnel plots showing the impact of initial low energy intake onalso performed based on the differences in daily protein
intake between the two groups (studies with different pro-
tein levels were in one subgroup and studies with the
same protein levels were in another subgroup) and
showed that mortality was not different between the LE
and HE groups in the different or same protein subgroup
(I2 = 0%; P = 0.87) (see Additional file 1).
Meta-analysis of secondary outcomes
Infectious complications
Six of the eight studies reported infections; these studies in-
cluded 1,683 patients [21-23,26-28]. The meta-analysis
showed no significant difference in infectious complications
between the LE and HE groups (RR, 1.09; 95% CI, 0.92 to
1.29; P = 0.32; I2 = 31%; P = 0.20).infections. RR, risk ratio; SE, standard error.
Figure 5 Funnel plots showing the impact of initial low energy intake on pneumonia. LE, low-energy; RR, risk ratio; SE, standard error.
Table 1 Characteristics of the enrolled studies
Study No. randomized Characteristics of patients BMI (SD) Mean APACHE II score (SD)
LE HE LE HE LE HE
Arabi et al. [21] 120 120 >18 years old 28.5 (7.4) 28.5 (8.4) 25.2 (7.5) 25.3 (8.2)
ICU >48 hours
Braunschweig et al. [22] 38 40 >18 years old 30.1 (8.9) 29.8 (9.3) 27.7 (7.9) 23.4 (9.3)
Medical or surgical ICU
ALI <24 hours
Charles et al. [23] 41 42 >18 years old 32.9 (2.0) 28.1 (0.9) 16.6 (0.9) 17.3 (0.8)
Artificial nutrition >48 hours
ICU >48 hours
Desachy et al. [24] 50 50 >18 years old 27 (5) 25 (3) 40 (11)1 42 (17)1
Medical or surgical ICU
Mechanical ventilation >72 hours
Peake et al. [25] 55 57 ≥18 years old 26.2 (6.4) 27.8 (7.9) 22 (8.9) 23 (9.1)
Enteral nutrition ≥2 days
Mechanical ventilation
Rice et al. [26] 98 102 ICU admission 29.2 (10.2) 28.2 (9.4) 26.9 (8.1) 26.9 (6.6)
Mechanical ventilation >72 hours
Rice et al. [27] 508 492 ICU admission 29.9 (7.8) 30.4 (8.2) 92 (28)2 90 (27)2
ALI <48 hours
Mechanical ventilation >72 hours
Taylor et al. [28] 41 41 Head injury necessitating mechanical ventilation N/A N/A 143 143
Glasgow Coma Scale >3
1Mean APACHE III score. 2Mean Simplified Acute Physiology Score II. 3Standard deviation was not reported. ALI, acute lung injury; APACHE, Acute Physiology And
Chronic Health Evaluation; BMI, body mass index; HE, high-energy; LE, low-energy; N/A, not available; SD, standard deviation.
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Daily target calorie supply (Kcal/kg) Mean daily percentage of caloric
goal (%)
Mean daily protein intake (g/kg)
LE HE LE HE LE HE
Arabi et al. [21] 7 N/A1 N/A1 59.0 71.4 65.2%2 63.7%2
Braunschweig et al. [22] 20 25-30 25-30 55.4 84.7 0.68 0.95
Charles et al. [23] 10-12 25-30 25-30 40.5 73 1.1 1.1
Desachy et al. [24] 5 25 25 76 95 N/A N/A
Peake et al. [25] 10 25-30 25-30 72 102 1.05 1.02
Rice et al. [26] 7 25-30 25-30 15 74.8 0.17 0.85
Rice et al. [27] 6 25-30 25-30 25 80 N/A N/A
Taylor et al. [28] 7 35 35 36.8 59.2 0.57 1.03
1The caloric requirement was estimated using the Harris-Benedict equation and adjusted for stress factors. 2The percentage of protein requirement was calculated
on the basis of patient condition and underlying diseases. HE, high-energy; LE, low-energy; N/A, not available.
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intake differences between the two groups. Relatively
higher daily protein and calorie intake decreased infection
in the different protein intake subgroups (RR, 1.25;
95% CI, 1.04 to 1.52; P = 0.02; I2 = 0%; P = 0.41). Interest-
ingly, when the daily protein intake was similar, infectious
complications were not different between the LE and HE
groups (RR, 0.94; 95% CI, 0.77 to 1.13; P = 0.50; I2 = 0%;Figure 6 Impact of initial low energy intake on mortality. CI, confidence inP = 0.92). There was significant heterogeneity among the
subgroups (I2 = 77.8%; P = 0.03) (Figure 7).
Pneumonia
Five of the eight studies reported infections; these stud-
ies included 1,605 patients [21,23,26-28]. Pneumonia
was not significantly different between the groups (RR,
1.12; 95% CI, 0.89 to 1.41; P = 0.33; I2 = 0%; P = 0.49).terval; LE, low energy; MH, Mantel-Haenszel.
Figure 7 Impact of initial low energy intake on infections. CI, confidence interval; MH, Mantel-Haenszel.
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affected by the percentage of the goal energy achieved
(I2 = 0%; P = 0.39) or the daily protein intake (I2 = 0%;
P = 0.67) (Figure 8).
Gastrointestinal intolerance
Three of the eight studies reported gastrointestinal in-
tolerance; these studies included 452 patients [21,24,25].
Patients initially receiving LE did not decrease the risk
of gastrointestinal intolerance compared with those ini-
tially receiving HE (RR, 0.84; 95% CI, 0.59 to 1.19;
P = 0.33; I2 = 20%; P = 0.29). Subgroup analysis showed
that gastrointestinal intolerance in the LE group that
was fed 33.3% to 66.6% of the goal energy was signifi-
cantly lower than that in the HE group (RR, 0.65; 95%
CI, 0.43 to 0.99; P = 0.05). However, this advantage was
not obvious in the LE group that was fed >66.6% of the
goal energy (RR, 1.06; 95% CI, 0.68 to 1.64; P = 0.80;
I2 = 0%; P = 0.86), compared with the HE group fed
>95% of the goal energy (Figure 9).
Length of intensive care unit stay
The data from four studies with 501 patients showed
no statistically significant differences for ICU LOS
between the two groups (WMD, −0.50; 95% CI, −2.99
to 1.99; P = 0.69; I2 = 22%; P = 0.28) [21-24]. Subgroup
analysis indicated that the LOS-HOS was not affected
by the percentage of the goal energy achieved (I2 = 0%;
P = 0.91) or daily protein intake (I2 = 0%; P = 0.97)
(see Additional file 2).Length of hospital stay
On the basis of the meta-analysis of four studies with
501 participants, the LOS-HOS was not significantly dif-
ferent between the groups (WMD, −1.64; 95% CI, −7.35
to 4.07; P = 0.57; I2 = 0%; P = 0.60) [21-24]. Subgroup
analysis indicated that LOS-HOS was not affected by the
percentage of the goal energy achieved (I2 = 0%; P = 0.80)
or daily protein intake (I2 = 0%; P = 0.39) (see Additional
file 3).
Mechanical ventilation days
For the two studies of 440 patients that provided data on
MVD, our meta-analysis showed no difference between
the LE and HE groups (WMD, −1.04; 95% CI, −3.29 to
1.20; P = 0.36; I2 = 46%; P = 0.17) [21,26] (Figure 10).
Discussion
In this meta-analysis of eight RCTs of critically ill adult
patients, there were no statistically significant differences
in mortality, infections, pneumonia, ICU LOS, LOS-HOS,
MVD or gastrointestinal intolerance between the LE and
HE groups. In the subgroup analysis of the LE group that
was fed between 33.3% and 66.6% of the goal energy, mor-
tality was significantly lower than in the HE group. Never-
theless, when the LE group was fed <33.3% or >66.6% of
the goal energy, this advantage in mortality was not
present, nor was the decreased risk for gastrointestinal in-
tolerance, compared with the HE group. Furthermore,
when the HE group received more protein than the LE
group, infections decreased. This advantage was no longer
Figure 9 Impact of initial low energy intake on gastrointestinal intolerance. CI, confidence interval; LE, low energy; MH, Mantel-Haenszel.
Figure 8 Impact of initial low energy intake on pneumonia. CI, confidence interval; LE, low energy; MH, Mantel-Haenszel.
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Figure 10 Impact of initial low energy intake on mechanical ventilation days. CI, confidence interval; IV, inverse variance; LE, low energy.
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however, these findings should be confirmed with add-
itional studies, given the methodological limitations of the
present study as described later in the discussion.
Current guidelines recommend that nutrition should
be provided to critically ill adults owing to the risk of
malnutrition. In addition, nutrition should be initiated as
soon as possible, ideally within 24 to 48 hours of ICU
admission [4,7,9]. Early EN improves outcomes in crit-
ical illness and may be the optimal delivery route in
those patients with adequate gastrointestinal tract func-
tion, compared with PN [5,7]. However, weak gastro-
intestinal function limits the effective delivery of EN. For
more effective delivery, supplemental parenteral nutri-
tion (SPN) was recently attempted; however, consistent
results were not obtained from different trials regarding
whether SPN results in harm, and no study showed clear
benefit [29]. Therefore, consensus regarding the early
use of SPN as a way to supply sufficient energy to pa-
tients does not exist [30-32]. Although PN may have re-
sulted in the negative outcomes in these studies, recent
RCTs have shown that PN does not harm the critically
ill [5]. Owing to the conflicting results, the calorie dose
is suspected as important for clinical outcomes in critic-
ally ill patients [5,33,34].
Since 2009, several cohort studies have investigated
the relationship between calorie intake and clinical out-
comes in critical illness. A multicentre cohort study of
2,772 patients in 2009 indicated that increased energy
and protein intake might be associated with reduced
mortality and MVD [35]. However, another cohort study
suggested that reduced caloric intake improves clinicaloutcomes in critically ill patients [36]. The nutrition
regimen in these studies involved EN, PN, and EN with
PN. Because the benefits of EN might be counteracted
by other nutrition regimens, the present meta-analysis
focused on calorie and protein intake using EN alone.
The recent major guidelines on EN in critically ill pa-
tients are not supported by our results [9,10], perhaps
because those recommendations were based on only two
previous RCTs [28,37]. However, more relevant studies,
including three related RCTs in the past year, have been
reported since the guidelines were published. The recent
meta-analysis by Choi and colleagues [20] of four RCTs
regarding the relationship between clinical outcomes
and EN-administered calories in critically ill adults
showed that overall mortality was significantly reduced
when underfed patients received ≥33.3% of the standard
caloric requirement; however, differences between sub-
groups of 33.3 to 66.6% and >66.6% standard caloric re-
quirements were not investigated because of the low
number of included studies. This is despite the results of
a previous cohort study that demonstrated that patients
in the middle tertile (33 to 65% of target energy) were
more likely to be discharged from the ICU with spontan-
eous ventilation than patients in the lowest and highest
tertiles [19]. The risk of gastrointestinal intolerance was
higher with increased energy supplied by EN; in turn,
mortality increased, which might support the benefits of
LE [12]. Similarly, in the present meta-analysis, mortality
was similar in the LE group who were fed >66.6% of the
goal energy compared with the HE group.
In addition, we found that decreased infection rates
might be attributed to HE combined with high protein
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studies that declared that a relatively higher protein in-
take might improve clinical outcomes [38,39]. Because
lower infection rates were observed with daily protein
intake ≥0.85 g/kg, compared with ≤0.68 g/kg, daily pro-
tein intake ≥0.85 g/kg might be effective for prevention
of infections, despite being lower than recommendations
(1.2 to 1.5 g/kg per day). Moreover, the finding that in-
fections did not increase mortality is noteworthy. It is
possible that mortality could not be determined by infec-
tions alone; for example, some infections may not be
serious enough to result in death. In the study by Taylor
and colleagues, infections were significantly higher in
the LE group without any differences in mortality be-
tween the LE and HE groups [28]. Similarly, in the study
by Braunschweig and colleagues [22], a dramatic in-
crease in mortality was observed in the HE group des-
pite relatively lower infection rates. That was possibly
explained by the increased mortality as patients who die
in ICU no longer develop infections. Furthermore, infec-
tious outcomes are more vulnerable to bias in these
often open-label studies, which might also explain the
isolated finding of fewer infectious diagnoses but no ef-
fect on clinical outcome. However, in the present study,
no specific search was conducted for low versus high
protein intake, and related RCTs for LE combined with
high protein intake were lacking. Moreover, we were not
able to explore other aspects, such as pneumonia or
LOS-HOS, because of the limited number of studies and
the diverse protein dose among studies. Therefore, we
could not provide an optimal range of daily protein in-
take, but we noted that, as protein intake increased, the
infection rate decreased. More studies using similar pro-
tocols are required to determine optimal intake levels. In
addition, none of the eight included studies showed that
patients were administrated the recommended amount
of protein, suggesting that protein deficiency might not
be appropriately addressed in clinical practice and daily
protein deficiency might impact clinical outcomes, such
as infections. More concern should be given to protein
supply in the critically ill patients in the future.
Although we attempted to reduce bias, the results of
the present study should be treated with caution because
of certain limitations. First, this meta-analysis included a
small number of studies; although we included four
studies more than a previous meta-analysis [20], data re-
garding gastrointestinal intolerance in the subgroup that
received <33.3% of the goal energy are lacking. Thus,
more high-quality studies are needed before a reliable
conclusion can be determined. Second, the disease se-
verity reported by the studies differed. The low APACHE
II scores in two studies were associated with low mortal-
ity, which might have contributed to heterogeneity
[23,28]. Third, the significant variations in calorie intakein the LE groups might have resulted in significant over-
lap between studies, potentially affecting the aggregated
results. We attempted to overcome this variability and
potential overlap through subgroup analysis, but the re-
sults should still be treated with caution. Fourth, the
data were presented differently between studies; for in-
stance, four studies presented the median MVD rather
than mean MVD [22,23,25,27]. Because we did not be-
lieve these should be used together in our meta-analysis,
only two studies were included in the MVD analysis. For
the same reason, only four of eight studies were included
in the ICU LOS and LOS-HOS analyses, and only one
of the four studies was in the different-protein subgroup,
while the other three studies were in the same-protein
subgroup. As a result, the ICU LOS and HOS-LOS in the
HE with high protein subgroup was only present in the
study by Braunschweig and colleagues rather than in
the aggregated results of four studies, and the results
could not accurately reflect whether HE with high protein
influences the LOS. Within the three studies of the same-
protein subgroup, the ICU LOS and LOS-HOS were not
different between the HE and LE groups. Therefore, the
pooled results could only suggest that no effects were
present in the comparison of the HE and LE groups. Fifth,
the intervention duration in three studies was longer than
in the other five studies; however, the results did not vary
significantly by subgroup analysis. Sixth, none of the se-
lected studies, except one, stated that the mean BMI of
patients was >25 kg/m2, which suggests that our conclu-
sions may not be appropriate for malnourished patients.
In addition, although the sensitivity analysis revealed that
the overall pooled results were stable, the conclusions for
the subgroups were affected; therefore, the results should
be interpreted with caution, and additional studies are
required.
Conclusions
In summary, there were no significant differences be-
tween the initial LE and HE groups of critically ill adult
patients. According to this meta-analysis, initial moder-
ate nutrient intake (33.3% to 66.6% of goal energy) as
compared to HE may reduce mortality, and a higher
protein intake combined with HE (≥0.85 g/kg per day)
may decrease the infection rates. However, because of
the study limitations, the optimal dose of initial calorie
and protein intake is still uncertain, and further large-
sample RCTs are needed to confirm our conclusions.
Key messages
 Initial moderately low calorie intake could improve
the prognosis of critical illness and excessively low
or high calorie intake should be avoided in these
patients.
Tian et al. Critical Care  (2015) 19:180 Page 12 of 13 A relatively high protein intake might benefit
critically ill patients, but the daily administration of
protein should not exceed the upper limit of the
recommended range.
 The current data are not sufficient to draw conclusions
regarding the optimal initial calorie and protein intake
to be administered by EN in non-malnourished
critically ill adults because of the limited number and
heterogeneity of the trials, including the varying calorie
and protein intake in the eight included studies.
 More rigorously designed studies using similar
protocols are required to determine the optimal
levels of calorie and protein intake.
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